APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Embryonic Stem Cells (HESC)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Embryonic Stem Cells (HESC) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchHuman Embryonic Stem Cells (HESC) Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Embryonic Stem Cells (HESC) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Human Embryonic Stem Cells (HESC) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Embryonic Stem Cells (HESC) Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Embryonic Stem Cells (HESC) Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Human Embryonic Stem Cells (HESC) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Embryonic Stem Cells (HESC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Embryonic Stem Cells (HESC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Embryonic Stem Cells (HESC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Embryonic Stem Cells (HESC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Embryonic Stem Cells (HESC) include ESI BIO, Thermo Fisher, Viacyte, Inc., UK Stem Cell Bank, TATAA Biocenter, Takara Bio, STEMCELL Technologies, Reliance Life Sciences and R&D Systems (Biotrchne), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Embryonic Stem Cells (HESC) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Embryonic Stem Cells (HESC) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Embryonic Stem Cells (HESC) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Embryonic Stem Cells (HESC) market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Embryonic Stem Cells (HESC) Segment by Company

ESI BIO

Thermo Fisher

Viacyte, Inc.

UK Stem Cell Bank

TATAA Biocenter

Takara Bio

STEMCELL Technologies

Reliance Life Sciences

R&D Systems (Biotrchne)

PerkinElmer

MilliporeSigma (Merck)

Fujifilm Cellular Dynamics

BioTime

BD Biosciences

Asterias Biotherapeutics

Astellas Institute of Regenerative Medicine

Human Embryonic Stem Cells (HESC) Segment by Type

Unipotent Stem Cells

Pluripotent Stem Cells

Totipotent Stem Cells

Human Embryonic Stem Cells (HESC) Segment by Application

Research

Clinical Trials

Others

Human Embryonic Stem Cells (HESC) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Embryonic Stem Cells (HESC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Embryonic Stem Cells (HESC) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Embryonic Stem Cells (HESC).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Embryonic Stem Cells (HESC) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Embryonic Stem Cells (HESC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Embryonic Stem Cells (HESC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Embryonic Stem Cells (HESC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Embryonic Stem Cells (HESC) Industry Trends Table 2. Human Embryonic Stem Cells (HESC) Industry Drivers Table 3. Human Embryonic Stem Cells (HESC) Industry Opportunities and Challenges Table 4. Human Embryonic Stem Cells (HESC) Industry Restraints Table 5. Global Human Embryonic Stem Cells (HESC) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Embryonic Stem Cells (HESC) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Manufacturers Table 9. Global Human Embryonic Stem Cells (HESC) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Human Embryonic Stem Cells (HESC) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Embryonic Stem Cells (HESC) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Embryonic Stem Cells (HESC) Manufacturers, Product Type & Application Table 13. Global Human Embryonic Stem Cells (HESC) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Embryonic Stem Cells (HESC) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Unipotent Stem Cells Table 17. Major Manufacturers of Pluripotent Stem Cells Table 18. Major Manufacturers of Totipotent Stem Cells Table 19. Global Human Embryonic Stem Cells (HESC) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Human Embryonic Stem Cells (HESC) Sales by Type (2021-2026) & (K Units) Table 21. Global Human Embryonic Stem Cells (HESC) Sales by Type (2027-2032) & (K Units) Table 22. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2021-2026) Table 23. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2027-2032) Table 24. Global Human Embryonic Stem Cells (HESC) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Human Embryonic Stem Cells (HESC) Revenue by Type (2021-2026) & (K Units) Table 26. Global Human Embryonic Stem Cells (HESC) Revenue by Type (2027-2032) & (K Units) Table 27. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2021-2026) Table 28. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Research Table 30. Major Manufacturers of Clinical Trials Table 31. Major Manufacturers of Others Table 32. Global Human Embryonic Stem Cells (HESC) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Human Embryonic Stem Cells (HESC) Sales by Application (2021-2026) & (K Units) Table 34. Global Human Embryonic Stem Cells (HESC) Sales by Application (2027-2032) & (K Units) Table 35. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2021-2026) Table 36. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2027-2032) Table 37. Global Human Embryonic Stem Cells (HESC) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Human Embryonic Stem Cells (HESC) Revenue by Application (2021-2026) & (K Units) Table 39. Global Human Embryonic Stem Cells (HESC) Revenue by Application (2027-2032) & (K Units) Table 40. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2021-2026) Table 41. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2027-2032) Table 42. Global Human Embryonic Stem Cells (HESC) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Human Embryonic Stem Cells (HESC) Sales by Region (2021-2026) & (K Units) Table 44. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2021-2026) Table 45. Global Human Embryonic Stem Cells (HESC) Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Human Embryonic Stem Cells (HESC) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units) Table 49. North America Human Embryonic Stem Cells (HESC) Sales by Country (2027-2032) & (K Units) Table 50. Europe Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units) Table 52. Europe Human Embryonic Stem Cells (HESC) Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Sales by Country (2027-2032) & (K Units) Table 59. Global Human Embryonic Stem Cells (HESC) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Human Embryonic Stem Cells (HESC) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Human Embryonic Stem Cells (HESC) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2021-2026) Table 63. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2027-2032) Table 64. ESI BIO Company Information Table 65. ESI BIO Business Overview Table 66. ESI BIO Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. ESI BIO Human Embryonic Stem Cells (HESC) Product Portfolio Table 68. ESI BIO Recent Development Table 69. Thermo Fisher Company Information Table 70. Thermo Fisher Business Overview Table 71. Thermo Fisher Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Thermo Fisher Human Embryonic Stem Cells (HESC) Product Portfolio Table 73. Thermo Fisher Recent Development Table 74. Viacyte, Inc. Company Information Table 75. Viacyte, Inc. Business Overview Table 76. Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product Portfolio Table 78. Viacyte, Inc. Recent Development Table 79. UK Stem Cell Bank Company Information Table 80. UK Stem Cell Bank Business Overview Table 81. UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product Portfolio Table 83. UK Stem Cell Bank Recent Development Table 84. TATAA Biocenter Company Information Table 85. TATAA Biocenter Business Overview Table 86. TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. TATAA Biocenter Human Embryonic Stem Cells (HESC) Product Portfolio Table 88. TATAA Biocenter Recent Development Table 89. Takara Bio Company Information Table 90. Takara Bio Business Overview Table 91. Takara Bio Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Takara Bio Human Embryonic Stem Cells (HESC) Product Portfolio Table 93. Takara Bio Recent Development Table 94. STEMCELL Technologies Company Information Table 95. STEMCELL Technologies Business Overview Table 96. STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product Portfolio Table 98. STEMCELL Technologies Recent Development Table 99. Reliance Life Sciences Company Information Table 100. Reliance Life Sciences Business Overview Table 101. Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product Portfolio Table 103. Reliance Life Sciences Recent Development Table 104. R&D Systems (Biotrchne) Company Information Table 105. R&D Systems (Biotrchne) Business Overview Table 106. R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product Portfolio Table 108. R&D Systems (Biotrchne) Recent Development Table 109. PerkinElmer Company Information Table 110. PerkinElmer Business Overview Table 111. PerkinElmer Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. PerkinElmer Human Embryonic Stem Cells (HESC) Product Portfolio Table 113. PerkinElmer Recent Development Table 114. MilliporeSigma (Merck) Company Information Table 115. MilliporeSigma (Merck) Business Overview Table 116. MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product Portfolio Table 118. MilliporeSigma (Merck) Recent Development Table 119. Fujifilm Cellular Dynamics Company Information Table 120. Fujifilm Cellular Dynamics Business Overview Table 121. Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product Portfolio Table 123. Fujifilm Cellular Dynamics Recent Development Table 124. BioTime Company Information Table 125. BioTime Business Overview Table 126. BioTime Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. BioTime Human Embryonic Stem Cells (HESC) Product Portfolio Table 128. BioTime Recent Development Table 129. BD Biosciences Company Information Table 130. BD Biosciences Business Overview Table 131. BD Biosciences Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. BD Biosciences Human Embryonic Stem Cells (HESC) Product Portfolio Table 133. BD Biosciences Recent Development Table 134. Asterias Biotherapeutics Company Information Table 135. Asterias Biotherapeutics Business Overview Table 136. Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product Portfolio Table 138. Asterias Biotherapeutics Recent Development Table 139. Astellas Institute of Regenerative Medicine Company Information Table 140. Astellas Institute of Regenerative Medicine Business Overview Table 141. Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product Portfolio Table 143. Astellas Institute of Regenerative Medicine Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Human Embryonic Stem Cells (HESC) Distributors List Table 147. Human Embryonic Stem Cells (HESC) Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Human Embryonic Stem Cells (HESC) Product Image Figure 2. Global Human Embryonic Stem Cells (HESC) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Embryonic Stem Cells (HESC) Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Embryonic Stem Cells (HESC) Sales (2021-2032) & (K Units) Figure 5. Global Human Embryonic Stem Cells (HESC) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Embryonic Stem Cells (HESC) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Unipotent Stem Cells Image Figure 9. Pluripotent Stem Cells Image Figure 10. Totipotent Stem Cells Image Figure 11. Global Human Embryonic Stem Cells (HESC) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Human Embryonic Stem Cells (HESC) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2021-2032) Figure 14. Global Human Embryonic Stem Cells (HESC) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Human Embryonic Stem Cells (HESC) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2021-2032) Figure 17. Research Image Figure 18. Clinical Trials Image Figure 19. Others Image Figure 20. Global Human Embryonic Stem Cells (HESC) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Human Embryonic Stem Cells (HESC) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2021-2032) Figure 23. Global Human Embryonic Stem Cells (HESC) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Human Embryonic Stem Cells (HESC) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2021-2032) Figure 26. North America Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2021-2032) Figure 28. U.S. Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2021-2032) Figure 33. Germany Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2021-2032) Figure 40. China Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2021-2032) Figure 48. Brazil Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Human Embryonic Stem Cells (HESC) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Human Embryonic Stem Cells (HESC) Revenue (2021-2032) & (US$ Million) Figure 59. North America Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Human Embryonic Stem Cells (HESC) Revenue (2021-2032) & (US$ Million) Figure 61. Europe Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Human Embryonic Stem Cells (HESC) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Human Embryonic Stem Cells (HESC) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Unipotent Stem Cells
  • Pluripotent Stem Cells
  • Totipotent Stem Cells
Applications
  • Research
  • Clinical Trials
  • Others
Companies covered
  • ESI BIO
  • Thermo Fisher
  • Viacyte, Inc.
  • UK Stem Cell Bank
  • TATAA Biocenter
  • Takara Bio
  • STEMCELL Technologies
  • Reliance Life Sciences
  • R&D Systems (Biotrchne)
  • PerkinElmer
  • MilliporeSigma (Merck)
  • Fujifilm Cellular Dynamics
  • BioTime
  • BD Biosciences
  • Asterias Biotherapeutics
  • Astellas Institute of Regenerative Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Embryonic Stem Cells (HESC) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Embryonic Stem Cells (HESC) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Embryonic Stem Cells (HESC) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Embryonic Stem Cells (HESC) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Embryonic Stem Cells (HESC) Market Dynamics
  1. 2.1 Human Embryonic Stem Cells (HESC) Industry Trends
  2. 2.2 Human Embryonic Stem Cells (HESC) Industry Drivers
  3. 2.3 Human Embryonic Stem Cells (HESC) Industry Opportunities and Challenges
  4. 2.4 Human Embryonic Stem Cells (HESC) Industry Restraints
3 Human Embryonic Stem Cells (HESC) Market by Manufacturers
  1. 3.1 Global Human Embryonic Stem Cells (HESC) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Embryonic Stem Cells (HESC) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Embryonic Stem Cells (HESC) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Embryonic Stem Cells (HESC) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Embryonic Stem Cells (HESC) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Embryonic Stem Cells (HESC) Manufacturers, Product Type & Application
  7. 3.7 Global Human Embryonic Stem Cells (HESC) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Embryonic Stem Cells (HESC) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Embryonic Stem Cells (HESC) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Embryonic Stem Cells (HESC) Tier 1, Tier 2, and Tier 3
4 Human Embryonic Stem Cells (HESC) Market by Type
  1. 4.1 Human Embryonic Stem Cells (HESC) Type Introduction
  2. 4.1.1 Unipotent Stem Cells
  3. 4.1.2 Pluripotent Stem Cells
  4. 4.1.3 Totipotent Stem Cells
  5. 4.2 Global Human Embryonic Stem Cells (HESC) Sales by Type
  6. 4.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Human Embryonic Stem Cells (HESC) Sales by Type (2021-2032)
  8. 4.2.3 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Human Embryonic Stem Cells (HESC) Revenue by Type
  10. 4.3.1 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2021-2032)
  12. 4.3.3 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2021-2032)
5 Human Embryonic Stem Cells (HESC) Market by Application
  1. 5.1 Human Embryonic Stem Cells (HESC) Application Introduction
  2. 5.1.1 Research
  3. 5.1.2 Clinical Trials
  4. 5.1.3 Others
  5. 5.2 Global Human Embryonic Stem Cells (HESC) Sales by Application
  6. 5.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Embryonic Stem Cells (HESC) Sales by Application (2021-2032)
  8. 5.2.3 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Human Embryonic Stem Cells (HESC) Revenue by Application
  10. 5.3.1 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2021-2032)
  12. 5.3.3 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2021-2032)
6 Global Human Embryonic Stem Cells (HESC) Sales by Region
  1. 6.1 Global Human Embryonic Stem Cells (HESC) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Embryonic Stem Cells (HESC) Sales by Region (2021-2032)
  3. 6.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Region (2021-2026)
  4. 6.2.2 Global Human Embryonic Stem Cells (HESC) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Embryonic Stem Cells (HESC) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Embryonic Stem Cells (HESC) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Embryonic Stem Cells (HESC) Revenue by Region
  1. 7.1 Global Human Embryonic Stem Cells (HESC) Revenue by Region
  2. 7.1.1 Global Human Embryonic Stem Cells (HESC) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Embryonic Stem Cells (HESC) Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Embryonic Stem Cells (HESC) Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Embryonic Stem Cells (HESC) Revenue (2021-2032)
  8. 7.2.2 North America Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Embryonic Stem Cells (HESC) Revenue (2021-2032)
  11. 7.3.2 Europe Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ESI BIO
  2. 8.1.1 ESI BIO Company Information
  3. 8.1.2 ESI BIO Business Overview
  4. 8.1.3 ESI BIO Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ESI BIO Human Embryonic Stem Cells (HESC) Product Portfolio
  6. 8.1.5 ESI BIO Recent Developments
  7. 8.2 Thermo Fisher
  8. 8.2.1 Thermo Fisher Company Information
  9. 8.2.2 Thermo Fisher Business Overview
  10. 8.2.3 Thermo Fisher Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Human Embryonic Stem Cells (HESC) Product Portfolio
  12. 8.2.5 Thermo Fisher Recent Developments
  13. 8.3 Viacyte, Inc.
  14. 8.3.1 Viacyte, Inc. Company Information
  15. 8.3.2 Viacyte, Inc. Business Overview
  16. 8.3.3 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product Portfolio
  18. 8.3.5 Viacyte, Inc. Recent Developments
  19. 8.4 UK Stem Cell Bank
  20. 8.4.1 UK Stem Cell Bank Company Information
  21. 8.4.2 UK Stem Cell Bank Business Overview
  22. 8.4.3 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product Portfolio
  24. 8.4.5 UK Stem Cell Bank Recent Developments
  25. 8.5 TATAA Biocenter
  26. 8.5.1 TATAA Biocenter Company Information
  27. 8.5.2 TATAA Biocenter Business Overview
  28. 8.5.3 TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 TATAA Biocenter Human Embryonic Stem Cells (HESC) Product Portfolio
  30. 8.5.5 TATAA Biocenter Recent Developments
  31. 8.6 Takara Bio
  32. 8.6.1 Takara Bio Company Information
  33. 8.6.2 Takara Bio Business Overview
  34. 8.6.3 Takara Bio Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Takara Bio Human Embryonic Stem Cells (HESC) Product Portfolio
  36. 8.6.5 Takara Bio Recent Developments
  37. 8.7 STEMCELL Technologies
  38. 8.7.1 STEMCELL Technologies Company Information
  39. 8.7.2 STEMCELL Technologies Business Overview
  40. 8.7.3 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product Portfolio
  42. 8.7.5 STEMCELL Technologies Recent Developments
  43. 8.8 Reliance Life Sciences
  44. 8.8.1 Reliance Life Sciences Company Information
  45. 8.8.2 Reliance Life Sciences Business Overview
  46. 8.8.3 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product Portfolio
  48. 8.8.5 Reliance Life Sciences Recent Developments
  49. 8.9 R&D Systems (Biotrchne)
  50. 8.9.1 R&D Systems (Biotrchne) Company Information
  51. 8.9.2 R&D Systems (Biotrchne) Business Overview
  52. 8.9.3 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product Portfolio
  54. 8.9.5 R&D Systems (Biotrchne) Recent Developments
  55. 8.10 PerkinElmer
  56. 8.10.1 PerkinElmer Company Information
  57. 8.10.2 PerkinElmer Business Overview
  58. 8.10.3 PerkinElmer Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 PerkinElmer Human Embryonic Stem Cells (HESC) Product Portfolio
  60. 8.10.5 PerkinElmer Recent Developments
  61. 8.11 MilliporeSigma (Merck)
  62. 8.11.1 MilliporeSigma (Merck) Company Information
  63. 8.11.2 MilliporeSigma (Merck) Business Overview
  64. 8.11.3 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product Portfolio
  66. 8.11.5 MilliporeSigma (Merck) Recent Developments
  67. 8.12 Fujifilm Cellular Dynamics
  68. 8.12.1 Fujifilm Cellular Dynamics Company Information
  69. 8.12.2 Fujifilm Cellular Dynamics Business Overview
  70. 8.12.3 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product Portfolio
  72. 8.12.5 Fujifilm Cellular Dynamics Recent Developments
  73. 8.13 BioTime
  74. 8.13.1 BioTime Company Information
  75. 8.13.2 BioTime Business Overview
  76. 8.13.3 BioTime Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BioTime Human Embryonic Stem Cells (HESC) Product Portfolio
  78. 8.13.5 BioTime Recent Developments
  79. 8.14 BD Biosciences
  80. 8.14.1 BD Biosciences Company Information
  81. 8.14.2 BD Biosciences Business Overview
  82. 8.14.3 BD Biosciences Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BD Biosciences Human Embryonic Stem Cells (HESC) Product Portfolio
  84. 8.14.5 BD Biosciences Recent Developments
  85. 8.15 Asterias Biotherapeutics
  86. 8.15.1 Asterias Biotherapeutics Company Information
  87. 8.15.2 Asterias Biotherapeutics Business Overview
  88. 8.15.3 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product Portfolio
  90. 8.15.5 Asterias Biotherapeutics Recent Developments
  91. 8.16 Astellas Institute of Regenerative Medicine
  92. 8.16.1 Astellas Institute of Regenerative Medicine Company Information
  93. 8.16.2 Astellas Institute of Regenerative Medicine Business Overview
  94. 8.16.3 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product Portfolio
  96. 8.16.5 Astellas Institute of Regenerative Medicine Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Embryonic Stem Cells (HESC) Value Chain Analysis
  2. 9.1.1 Human Embryonic Stem Cells (HESC) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Embryonic Stem Cells (HESC) Production Mode & Process
  6. 9.2 Human Embryonic Stem Cells (HESC) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Embryonic Stem Cells (HESC) Distributors
  9. 9.2.3 Human Embryonic Stem Cells (HESC) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst